Compositions and their uses directed to IL-4R alpha

Details for Australian Patent Application No. 2006216514 (hide)

Owner Isis Pharmaceuticals, Inc.

Inventors Gregory, Susan; Karras, James G.; Freier, Susan M.; Tung, David; Wedel, Mark K.; Crosby, Jeffrey R.

Agent Wrays

Pub. Number AU-B-2006216514

PCT Pub. Number WO2006/091841

Priority 60/709,404 18.08.05 US; 60/656,760 25.02.05 US; 60/688,897 09.06.05 US; 60/700,656 19.07.05 US

Filing date 24 February 2006

Wipo publication date 31 August 2006

Acceptance publication date 16 February 2012

International Classifications

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

C12N 15/113 (2010.01) Mutation or genetic engineering - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides

Event Publications

6 September 2007 PCT application entered the National Phase

  PCT publication WO2006/091841 Priority application(s): WO2006/091841

16 February 2012 Application Accepted

  Published as AU-B-2006216514

7 June 2012 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 24 Apr 2012. Address for service in Australia - Pizzeys PO Box 291 Woden Canberra ACT 2606

27 September 2012 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 24 Apr 2012

4 October 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006216517-Small public-key based digital signatures for authentication

2006216510-Small molecule inhibitors of STAT3 and the uses thereof